Literature DB >> 19348976

Explanatory and pragmatic attitudes in therapeutical trials.

Daniel Schwartz1, Joseph Lellouch.   

Abstract

It is the thesis of this paper that most therapeutic trials are inadequately formulated, and this from the earliest stages of their conception. Their inadequacy is basic, in that the trials may be aimed at the solution of one or other of two radically different kinds of problem; the resulting ambiguity affects the definition of the treatments, the assessment of the results, the choice of subjects and the way in which the treatments are compared. It often occurs that one type of approach is ethically less defensible than the other, or may even be ruled out altogether on ethical grounds. We postpone consideration of this aspect of the question until a later section.

Year:  2009        PMID: 19348976     DOI: 10.1016/j.jclinepi.2009.01.012

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  85 in total

1.  Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.

Authors:  Bo Ahrén; Chantal Mathieu; Giovanni Bader; Anja Schweizer; James E Foley
Journal:  Diabetologia       Date:  2014-03-29       Impact factor: 10.122

2.  Are explanatory trials ethical? Shifting the burden of justification in clinical trial design.

Authors:  Kirstin Borgerson
Journal:  Theor Med Bioeth       Date:  2013-08

Review 3.  Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.

Authors:  Hans-Georg Eichler; Brigitte Bloechl-Daum; Eric Abadie; David Barnett; Franz König; Steven Pearson
Journal:  Nat Rev Drug Discov       Date:  2010-02-26       Impact factor: 84.694

4.  Creative trial design in RA: optimizing patient outcomes.

Authors:  Maya H Buch; Sue Pavitt; Mahesh Parmar; Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2013-02-05       Impact factor: 20.543

Review 5.  Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.

Authors:  James R Rogers; Junghwan Lee; Ziheng Zhou; Ying Kuen Cheung; George Hripcsak; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2021-01-15       Impact factor: 4.497

6.  Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: The PRoMPT BOLUS Randomized Controlled Trial Pilot Feasibility Study.

Authors:  Fran Balamuth; Marlena Kittick; Peter McBride; Ashley L Woodford; Nicole Vestal; T Charles Casper; Melissa Metheney; Katherine Smith; Natalie J Atkin; Jill M Baren; J Michael Dean; Nathan Kuppermann; Scott L Weiss
Journal:  Acad Emerg Med       Date:  2019-07-18       Impact factor: 3.451

7.  Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis.

Authors:  Ashly E Jordan; David C Perlman; Daniel J Smith; Jennifer R Reed; Holly Hagan
Journal:  J Clin Epidemiol       Date:  2017-11-02       Impact factor: 6.437

8.  Achieving Milestones as a Prerequisite for Proceeding With a Clinical Trial.

Authors:  Angela M Mickle; Hannah R Maybrier; Anke C Winter; Sherry L McKinnon; Brian A Torres; Nan Lin; Eric J Lenze; Susan Stark; Maxwell R Muench; Eric Jacobsohn; Sharon K Inouye; Michael S Avidan; Troy S Wildes
Journal:  Anesth Analg       Date:  2018-06       Impact factor: 5.108

9.  Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews.

Authors:  L Susan Wieland; Brian M Berman; Douglas G Altman; Jürgen Barth; Lex M Bouter; Christopher R D'Adamo; Klaus Linde; David Moher; C Daniel Mullins; Shaun Treweek; Sean Tunis; Danielle A van der Windt; Merrick Zwarenstein; Claudia Witt
Journal:  J Clin Epidemiol       Date:  2017-02-07       Impact factor: 6.437

Review 10.  Approaches to Mixed Methods Dissemination and Implementation Research: Methods, Strengths, Caveats, and Opportunities.

Authors:  Carla A Green; Naihua Duan; Robert D Gibbons; Kimberly E Hoagwood; Lawrence A Palinkas; Jennifer P Wisdom
Journal:  Adm Policy Ment Health       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.